BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chung W, Promrat K, Wands J. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. World J Hepatol 2020; 12(9): 533-557 [PMID: 33033564 DOI: 10.4254/wjh.v12.i9.533]
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/533.htm
Number Citing Articles
Ji-Xian Song, Ji-Ren An, Qi Chen, Xin-Yue Yang, Cui-Ling Jia, Shan Xu, Ya-shuo Zhao, En-Sheng Ji. Liraglutide attenuates hepatic iron levels and ferroptosis in db/db miceBioengineered 2022; 13(4): 8334 doi: 10.1080/21655979.2022.2051858
Zahra Tolou-Ghamari, Abbas-Ali Palizban. Biomarkers, Biocatalysts, or Pathology Conditions to Evaluate Potential History of Liver Disease such as CancerClinical Cancer Investigation Journal 2022; 11(6): 31 doi: 10.51847/caGjAHyB9E
Ahmed Abdallah Salman, Mohamed Abdalla Salman, Mostafa Said, Hesham Elkassar, Mohammad El Sherbiny, Ahmed Youssef, Mohammed Elbaz, Ahmed M. Elmeligui, Mohamed Badr Hassan, Mahmoud Gouda Omar, Hussien Samir, Mohamed Abdelkader Morad, Hossam El-Din Shaaban, Mohamed Youssef, Ahmed Moustafa, Mohamed Sabry Tourky, Ahmed Elewa, Sadaf Khalid, Khaled Monazea, Mohamed Shawkat. Albuminuria as a predictor of mortality in type II diabetic patients after living-donor liver transplantationAnnals of Medicine 2022; 54(1): 2597 doi: 10.1080/07853890.2022.2124446
Chuxin Huang, Jiali Qian, Ying Liu, Li Zhang, Yehong Yang. Empagliflozin attenuates liver fibrosis in high‐fat diet/streptozotocin‐induced mice by modulating gut microbiotaClinical and Experimental Pharmacology and Physiology 2024; 51(3) doi: 10.1111/1440-1681.13842
Eman Yousef Moursi, Pacint Elsayed Moez, Ehab Mostafa Hassouna, Eman Zakareya Elkemary, Geilan Mahmoud Marei, Mohammed Said Sayed Shater, Mai Hesham Mohammed Badrah. MALAT1 and MEG3 genes expression in non-alcoholic fatty liver disease in type 2 diabetes mellitus patients: a case-control studyAlexandria Journal of Medicine 2023; 59(1): 86 doi: 10.1080/20905068.2023.2251221
Si Ho Kim, Eun Ju Cho, Boo‐ok Jang, Kyunghan Lee, Jae Kyun Choi, Gwang Hyeon Choi, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Yun Bin Lee, Jeong‐Hwan Yoon, Jin‐Wook Kim, Sook‐Hyang Jeong, Eun Sun Jang. Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infectionLiver International 2022; 42(2): 320 doi: 10.1111/liv.15086
Juan Eduardo Quiroz-Aldave, Elman Rolando Gamarra-Osorio, María del Carmen Durand-Vásquez, Luciana del Pilar Rafael-Robles, Jhean Gabriel Gonzáles-Yovera, María Alejandra Quispe-Flores, Luis Alberto Concepción-Urteaga, Alejandro Román-González, José Paz-Ibarra, Marcio José Concepción-Zavaleta. From liver to hormones: The endocrine consequences of cirrhosisWorld Journal of Gastroenterology 2024; 30(9): 1073-1095 doi: 10.3748/wjg.v30.i9.1073
Alessandro Mantovani, Giovanni Targher, Christopher D. Byrne. Textbook of Diabetes2024; : 820 doi: 10.1002/9781119697473.ch57
Laurent Castera, Kenneth Cusi. Diabetes and cirrhosis: Current concepts on diagnosis and managementHepatology 2023; 77(6): 2128 doi: 10.1097/HEP.0000000000000263
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCCHepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the HepatologistJournal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider. The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018Endocrinology and Metabolism 2022; 37(3): 455 doi: 10.3803/EnM.2022.1434